The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1852-1858

  Sukumar, D ^a   Partridge, N C ^b   Wang, X ^c   Shapses, Sue A ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 PROPEPTIDE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCALCIN; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE TURNOVER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPARATHYROIDISM; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADIPOSITY; ADULT; AGED; ANALYSIS OF VARIANCE; BONE DENSITY; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; HUMANS; MIDDLE AGED; OBESITY; PARATHYROID HORMONE; REGRESSION ANALYSIS;

EID: 79956318817     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2781     Document Type: Article

References (38)

1. Bilezikian JP, Rubin M, Silverberg SJ 2006 Asymptomatic primary hyperparathyroidism. Arq Bras Endocrinol Metab 50:647-656 (Pubitemid 44786001)
2. Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S; SIPH Study Group Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94:2255-2261
3. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K 1996 Circulating levels of interleukin-6 and tumor necrosis factor-α are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - a clinical research center study. J Clin Endocrinol Metab 81:3450-3454 (Pubitemid 26339897)
4. Li X, Qin L, Bergenstock M, Bevelock LM, Novack DV, Partridge NC 2007 Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem 282:33098-33106 (Pubitemid 350159306)
5. Rollins BJ 1996 Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204 (Pubitemid 126401890)
6. Arakelyan A, Petrkova J, Hermanova Z, Boyajyan A, Lukl J, Petrek M 2005 Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm 2005:175-179 (Pubitemid 41381527)
7. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D 1991 Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256 (Pubitemid 21914722)
8. Sartipy P, Loskutoff DJ 2003 Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100:7265-7270 (Pubitemid 36706427)
9. Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R 2006 Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30:1347-1355 (Pubitemid 44306516)
10. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, BouloumiéA, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clément K 2005 Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54:2277-2286 (Pubitemid 41134253)
11. Christiansen T, Richelsen B, Bruun JM 2005 Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29:146-150 (Pubitemid 40065478)
12. Tamasi J, Shimizu E, Benton N, Johnson J, Morrison N, Partridge N 2010 The anabolic action of parathyroid hormone on bone is mediated by monocyte chemoattractant protein-1. J Bone Miner Res 25(Suppl 1):S94 (Abstract)
13. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, de Lemos JA 2004 Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44: 1812-1818 (Pubitemid 39424080)
14. Chang E, Donkin SS, Teegarden D 2009 Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol 307: 77-82
15. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J 2009 Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765-2771
16. Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR 2006 Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 38:317-321 (Pubitemid 43255425)
17. Pitroda AP, Harris SS, Dawson-Hughes B 2009 The association of adiposity with parathyroid hormone in healthy older adults. Endocrine 36:218-223
18. Sukumar D, Schlussel Y, Riedt CS, Gordon C, Stahl T, Shapses SA 2011 Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int 22:635-645
19. Bolland MJ, Grey AB, Gamble GD, Reid IR 2005 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90:1525-1530 (Pubitemid 40464014)
20. Ni Z, Smogorzewski M, Massry SG 1994 Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 135: 1837-1844 (Pubitemid 24363874)
21. Gunther CW, Lyle RM, Legowski PA, James JM, McCabe LD, Mc-Cabe GP, Peacock M, Teegarden D 2005 Fat oxidation and its relation to serum parathyroid hormone in young women enrolled in a 1-y dairy calcium intervention. Am J Clin Nutr 82:1228-1234 (Pubitemid 43779721)
22. Teegarden D, White KM, Lyle RM, Zemel MB, Van Loan MD, Matkovic V, Craig BA, Schoeller DA 2008 Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16:1566-1572 (Pubitemid 351915103)
23. Ricci TA, Heymsfield SB, Pierson Jr RN, Stahl T, Chowdhury HA, Shapses SA 2001 Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 73:347-352 (Pubitemid 32109866)
24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693 (Pubitemid 30667088)
25. Teegarden D, Legowski P, Gunther CW, McCabe GP, Peacock M, Lyle RM 2005 Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss. J Clin Endocrinol Metab 90:5127-5133 (Pubitemid 41262264)
26. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA 2004 The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89:1196-1199 (Pubitemid 38368412)
27. Arunabh S, Pollack S, Yeh J, Aloia JF 2003 Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157-161 (Pubitemid 36115158)
28. Kamycheva E, Sundsfjord J, Jorde R 2004 Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 151:167-172 (Pubitemid 39207010)
29. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W 2007 Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157:225-232 (Pubitemid 47233129)
30. Andersen T, McNair P, Hyldstrup L, Fogh-Andersen N, Nielsen TT, Astrup A, Transbøl I 1988 Secondary hyperparathyroidism of morbid obesity regresses during weight reduction. Metabolism 37:425-428
31. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H 2003 Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278:46654-46660 (Pubitemid 37452242)
32. Tateya S, Tamori Y, Kawaguchi T, Kanda H, Kasuga M 2010 An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 151:971-979
33. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T 2006 Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281:26602-26614 (Pubitemid 44401869)
34. Duan Y, De Luca V, Seeman E 1999 Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84:718-722 (Pubitemid 29075711)
35. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, Bilezikian JP 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80:723-728
36. Nakchbandi IA, Mitnick MA, Lang R, Gundberg C, Kinder B, Insogna K 2002 Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 87:4946-4951 (Pubitemid 35316330)
37. Khan A, Bilezikian J 2000 Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184-187 (Pubitemid 30625659)
38. Charopoulos I, Tournis S, Trovas G, Raptou P, Kaldrymides P, Skarandavos G, Katsalira K, Lyritis GP 2006 Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women. J Clin Endocrinol Metab 91:1748-1753